Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
Resource Type
Article
Authors
Harvey-Jones, E. ; Raghunandan, M. ; Robbez-Masson, L. ; Magraner-Pardo, L. ; Alaguthurai, T. ; Yablonovitch, A. ; Yen, J. ; Xiao, H. ; Brough, R. ; Frankum, J. ; Song, F. ; Yeung, J. ; Savy, T. ; Gulati, A. ; Alexander, J. ; Kemp, H. ; Starling, C. ; Konde, A. ; Marlow, R. ; Cheang, M. ; Proszek, P. ; Hubank, M. ; Cai, M. ; Trendell, J. ; Lu, R. ; Liccardo, R. ; Ravindran, N. ; Llop-Guevara, A. ; Rodriguez, O. ; Balmana, J. ; Lukashchuk, N. ; Dorschner, M. ; Drusbosky, L. ; Roxanis, I. ; Serra, V. ; Haider, S. ; Pettitt, S.J. ; Lord, C.J. ; Tutt, A.N.J.
Source
In Annals of Oncology April 2024 35(4):364-380
Subject
Breast tumors
Language
ISSN
0923-7534